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ICP27 is an essential herpes simplex virus type 1 (HSV-1) nuclear protein which regulates viral early and late genes during
infection. The exact mechanism by which ICP27 modulates viral gene expression is unknown, but considerable evidence
suggests that it functions posttranscriptionally. In this study, we have asked whether ICP27, like some other viral and cellular
posttranscriptional regulatory proteins, shuttles between the nuclear and cytoplasmic compartments of the cell. Using an
interspecies heterokaryon assay, we demonstrate that ICP27, but not the HSV-1 nuclear proteins ICP4 or ICP8, is an efficient
shuttling protein. ICP27’s shuttling ability does not depend on viral infection or other HSV-1 proteins, as it shuttles even when
transiently expressed in uninfected cells. To understand the importance of shuttling for ICP27’s regulatory functions, we
examined several mutant forms of ICP27 to see whether they exhibited altered shuttling. We identified three ICP27 mutations
which partially disrupt shuttling, as well as one mutation, M15, which completely abrogates this activity. The M15 mutation
alters residues 465 and 466 near the carboxyl terminus of ICP27 and was previously shown to inactivate ICP27’s ability to
induce certain viral late mRNAs. These results suggest that ICP27’s nuclear shuttling activity is involved in its viral late gene
activation function. © 1998 Academic Press
INTRODUCTION
Herpes simplex virus type 1 (HSV-1), an extensively
studied human alphaherpesvirus, serves as a very useful
model for studying how herpesviruses use the RNA poly-
merase II transcription machinery and other cellular
components for their gene expression. During lytic infec-
tion, the .75 HSV-1 genes are expressed in a temporally
regulated cascade consisting of three major waves of
viral gene expression (Honess and Roizman, 1974; re-
viewed in Roizman and Sears, 1996). These are referred
to as the immediate-early (IE or a), delayed-early (DE or
b), and late (L or g) phases. The IE genes are expressed
immediately upon infection and encode four gene regu-
latory factors (ICP0, ICP4, ICP22, and ICP27) and an
immunological modulator (ICP47). DE genes are ex-
pressed next; these mostly encode proteins involved in
viral DNA replication. Finally, L genes are expressed.
These predominantly encode virion structural proteins,
and their expression is stimulated by the process of viral
DNA synthesis. At the same time that the virus uses the
cellular machinery to express its own genes, it efficiently
represses host gene expression, at both transcriptional
and posttranscriptional levels (reviewed in Smiley et al.,
1991; Spencer et al., 1997).
We have been investigating the role of the IE protein
ICP27 in HSV-1 gene regulation. ICP27, also known as
IE63, is a nuclear protein consisting of 512 amino acid
residues. It plays an essential role in viral gene expres-
sion, being required for the progression of the viral in-
fection into the L phase (Sacks et al., 1985; McCarthy et
al., 1989; Rice and Knipe, 1990). Based on the phenotypic
analysis of viral mutants, it can be concluded that ICP27
carries out two distinct functions that contribute to L
phase activation (Rice and Knipe, 1990; Rice et al., 1993).
First, ICP27 increases the level of viral DNA replication
up to 10-fold (Rice and Knipe, 1990), most likely by trans-
activating a subset of DE genes involved in DNA repli-
cation (Uprichard and Knipe, 1996; McGregor et al., 1996).
Second, ICP27 stimulates L gene mRNA expression by a
mechanism that does not involve the stimulation of viral
DNA replication (Rice and Knipe, 1990; Rice and Lam,
1994; Hibbard and Sandri-Goldin, 1995). In addition to its
stimulatory effects on viral genes, ICP27 also down-
regulates the expression of some viral IE and DE genes
during infection (Sacks et al., 1985; McCarthy et al., 1989;
Rice and Knipe, 1990). Furthermore, ICP27 contributes to
the shutoff of host gene expression, as both cellular
protein synthesis (Sacks et al., 1985) and mRNA levels
(Hardwicke and Sandri-Goldin, 1994) are elevated in
ICP27 mutant infections compared to wild-type (WT)
HSV-1 infection.
The exact mechanism(s) by which ICP27 regulates
viral and cellular genes during HSV-1 infection is un-
known. However, considerable evidence indicates that it
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functions, at least in part, at the posttranscriptional level.
Under various experimental circumstances, ICP27 can
modulate the efficiency of pre-mRNA polyadenylation
(McLauchlan et al., 1992; Sandri-Goldin and Mendoza,
1992; McGregor et al., 1996), alter the intranuclear dis-
tribution of pre-mRNA splicing factors (Phelan et al.,
1993; Sandri-Goldin et al., 1995), inhibit pre-mRNA splic-
ing (Hardy and Sandri-Goldin, 1994), increase the stabil-
ity of specific cellular mRNAs (Brown et al., 1995), and
inhibit the nuclear export of intron-containing viral tran-
scripts (Phelan et al., 1996). Consistent with these post-
transcriptional effects, recent studies have shown that
ICP27 can bind directly to RNA (Brown et al., 1995;
Ingram et al., 1996; Mears and Rice, 1996), although the
nature of ICP27’s putative in vivo RNA target(s) is not yet
known.
In the past few years, several nuclear-localized RNA-
binding proteins involved in posttranscriptional gene reg-
ulation, including HIV-1 Rev (Kalland et al., 1994; Meyer
and Malim, 1994) and several cellular hnRNP proteins
(Pin˜ol-Roma and Dreyfuss, 1992; Flach et al., 1994), have
been shown to be nuclear shuttling proteins. That is,
although the steady-state localization of these proteins is
predominantly nuclear, they can be demonstrated to
move continuously between the nuclear and the cyto-
plasmic compartments of the cell. Given ICP27’s nuclear
localization, RNA-binding activity, and posttranscriptional
effects on gene expression, we asked in this study
whether ICP27 is a nuclear shuttling protein. Our results
demonstrate that ICP27 is indeed such a protein, and we
provide evidence that this activity is important for ICP27’s
gene regulation function.
RESULTS
Nuclear shuttling of ICP27 in interspecies
heterokaryons
ICP27’s nuclear localization, RNA-binding activity, and
posttranscriptional effects on gene expression suggest
the possibility that it shuttles between the nucleus and
the cytoplasm of cells, similar to what has been ob-
served for some other posttranscriptional regulatory pro-
teins including several hnRNP proteins and HIV-1 Rev
(Pin˜ol-Roma and Dreyfuss, 1992; Flach et al., 1994; Kal-
land et al., 1994; Meyer and Malim, 1994). To see if ICP27
is a shuttling protein, we utilized an interspecies hetero-
karyon assay that has been developed to identify and
study shuttling proteins (Borer et al., 1989; Pin˜ol-Roma
and Dreyfuss, 1993). We modified the assay slightly, as
indicated in Fig. 1, to apply it to HSV-1 nuclear proteins.
In our modified assay, Vero monkey cells are infected
with HSV-1 for 4 h and then treated with cycloheximide to
prevent further protein synthesis. The infected Vero cells
are then fused, using polyethylene glycol, to uninfected
3T6 mouse cells in the presence of cycloheximide and
human immune globulin to prevent infection of the
mouse cells by residual virus. One hour later, the local-
ization of viral nuclear proteins in the interspecies het-
erokaryons is assessed by indirect immunofluores-
cence. Since protein synthesis is inhibited, the appear-
ance of an HSV-1 nuclear protein in a mouse nucleus of
an interspecies heterokaryon suggests that the viral pro-
tein has shuttled out of the infected monkey nucleus and
been re-imported into the uninfected mouse nucleus.
In the first set of experiments, the interspecies hetero-
karyon assay was used to examine the ability of ICP27 to
shuttle. After cell fusion, fixation, and staining, cellular
heterokaryons were identified by phase microscopy (Fig.
2A) and microscopic visualization of stress fibers using
FITC–phallocidin, which stains polymerized actin (not
shown). To differentiate monkey nuclei from mouse nu-
clei, cells were also stained with Hoechst 33258 dye.
Monkey nuclei stain relatively diffusely with this reagent,
whereas mouse nuclei exhibit a characteristic speckled
pattern (Fig. 2B; the mouse nucleus is indicated by an
arrow). Examination of numerous interspecies hetero-
karyons indicated that nearly all which contained ICP27
in their monkey nuclei also displayed ICP27 in their
mouse nuclei (Fig. 2C). As expected, ICP27 was never
observed in unfused mouse cells, indicating that the
experimental protocol had successfully prevented pro-
FIG. 1. Schematic diagram showing the interspecies heterokaryon
assay used to test the shuttling of HSV-1 nuclear proteins. The appear-
ance of a viral protein in the mouse nucleus of an interspecies hete-
reokaryon suggests that the protein has shuttled from the infected
monkey nucleus.
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FIG. 2. Trafficking of ICP27, ICP4, and ICP8 in interspecies heterokaryons. A–C, D–F, and G–I show fields of cells stained for ICP27, ICP4, and ICP8,
respectively. Each series shows a single field of cells containing one or more interspecies heterokaryons. The arrows denote the mouse nuclei in
the interspecies heterokaryons. (A), (D), and (G): Phase-contrast images. (B), (E), and (H): Hoechst staining. Note that 3T6 mouse nuclei show an
intense speckled pattern, while Vero monkey nuclei exhibit more diffuse staining. (C) ICP27 staining, using mouse monoclonal antibody H1119. ICP27
staining in the nucleus indicated was scored as ‘‘strong.’’ (F) ICP4 staining, using mouse monoclonal antibody H1114. The nuclei indicated were
negative for ICP4 staining. (I) ICP8 staining, using mouse monoclonal antibody H1115. ICP8 staining in the nucleus indicated was scored as ‘‘weak.’’
Bar, 20 mm.
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ductive infection of the mouse cells. These results indi-
cate that ICP27 is a nuclear shuttling protein.
Analysis of other HSV-1 nuclear proteins
To see if other HSV-1 nuclear proteins behave similarly
to ICP27 in the interspecies heterokaryon assay, we
carried out additional experiments in which we exam-
ined the viral nuclear proteins ICP4 and ICP8, in addition
to ICP27. The IE protein ICP4 is an essential transcrip-
tional transactivator with sequence-specific DNA-bind-
ing activity, whereas the DE protein ICP8 is an essential
DNA replication protein with nonspecific single-stranded
DNA-binding activity (Roizman and Sears, 1996). Intranu-
clear trafficking was assessed semiquantitatively by ex-
amining numerous (.100) interspecies heterokaryons
for each of the proteins under investigation. The degree
of viral protein staining within the mouse nucleus of each
interspecies heterokaryon was determined visually and
scored as either strong or weak, based on its staining
relative to the infected monkey nucleus (or nuclei) in the
same heterokaryon. Although the division of viral protein
staining into these two categories was somewhat sub-
jective, we found this distinction helpful, because in
some cases staining of mouse nuclei was quite weak
(see below).
The results of this analysis are shown in Table 1. For
ICP27, the results were consistent with those of the
previous experiment. In this case, 100% (114/114) of the
interspecies heterokaryons which were scored had
mouse nuclei which stained positively for ICP27, in most
cases (;95%) strongly. It should be noted that a number
of HSV-1-infected monkey cells, both fused and unfused,
showed a low level of cytoplasmic ICP27 staining, in
addition to strong nuclear staining. Interspecies hetero-
karyons that contained significant cytoplasmic ICP27
invariably showed positive mouse nuclei. These were
excluded from the analysis presented in Table 1, as it
seemed possible that the ICP27 in the mouse nuclei
could have originated from the Vero cell cytoplasm,
rather than from Vero cell nuclei. The results for ICP4 and
ICP8, which were predominantly nuclear in their local-
ization, were quite different than those for ICP27. These
proteins were detected in mouse nuclei in only a minority
of interspecies heteryokaryons (;15 and ;32% for ICP4
and ICP8, respectively), and in these cases, staining was
nearly invariably weak. Two representative interspecies
heterokaryons stained for ICP4 are shown in Figs. 2D–
2F. Note that no ICP4 is detectable in these mouse
nuclei. A representative heterokaryon stained for ICP8 is
shown in Figs. 2G–2I. In this case, weak ICP8 staining
can be detected in the mouse nucleus of the hetero-
karyon. These results demonstrate that, unlike ICP27,
ICP4 and ICP8 are not efficient nuclear shuttling pro-
teins.
Analysis of viral ICP27 mutants
If ICP27’s ability to shuttle between nucleus and cyto-
plasm is biologically important, then this activity may be
disrupted by mutations which affect ICP27’s regulatory
functions. To investigate this possibility, we examined
the shuttling ability of several mutant polypeptides en-
coded by replication-defective HSV-1 ICP27 mutants. The
mutants used were d1-2, which encodes an ICP27
polypeptide having a deletion of an acidic region near
the amino (N)-terminus (Rice et al., 1993), and n504R,
M11, M15, and M16, which encode molecules having
alterations in the carboxyl (C)-terminal half of ICP27. The
n504R mutant has a nonsense mutation near the C-
terminus of the ICP27 coding region and expresses only
504 of ICP27’s 512 residues (Rice and Knipe, 1990). The
M11, M15, and M16 mutations result in amino acid sub-
stitutions at residues 340/341, 465/466, and 488, respec-
tively (Rice and Lam, 1994). In preliminary experiments,
we found that several of the mutant molecules were
expressed poorly under the conditions of prolonged cy-
cloheximide treatment (data not shown), perhaps as a
result of reduced protein stability relative to the WT
protein. To increase the levels of ICP27 for analysis, we
modified the conditions of infection by using a ‘‘cyclohex-
imide release’’ protocol to enhance the expression of
viral IE proteins (Honess and Roizman, 1974). To do this,
Vero cells were infected in the presence of cyclohexi-
mide for 4 h to allow IE transcripts to accumulate to high
levels. The cells were then washed, and protein synthe-
sis was allowed to proceed for 2 h. Uninfected mouse
cells and cycloheximide were then added and hetero-
karyons were formed as previously described. This
change to the protocol resulted in comparable levels of
WT and mutant molecules immediately prior to the cell
fusion step. This is shown for the WT, M15, and n504R
polypeptides in Figs. 3A, 3E, and 3I.
TABLE 1
Trafficking of HSV-1 Nuclear Proteins
within Interspecies Heterokaryons
Viral protein
No. of
heterokaryons
examined
Staining of mouse nuclei in
interspecies heterokaryons
(%)
Positive
Negative11a 1b
ICP27 114 94.7 5.3 0
ICP4 114 0 14.9 85.1
ICP8 115 0.9 31.3 67.8
a (11) Strong staining within mouse nuclei (visually comparable in
intensity to that observed in Vero nuclei of the same heterokaryon).
b (1) Weak staining within mouse nuclei (visually less than half the
staining intensity observed in Vero nuclei of same heterokaryon).
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Using the cycloheximide reversal protocol, the shut-
tling abilities of the five mutant forms of ICP27 were
compared to that of the WT protein. For each virus,
numerous (.200) interspecies heterokaryons were ex-
amined microscopically, and the degree of ICP27 stain-
ing within mouse nuclei of interspecies heterokaryons
was scored as either strong or weak using the criteria
described earlier. The results of this analysis are shown
in Table 2. As expected from the previous experiments,
WT ICP27 efficiently shuttled between nuclei, showing
staining in the great majority (;94–98%) of mouse nuclei
of interspecies heterokaryons. In most cases (.83%),
staining was strong. An example of WT ICP27’s ability to
shuttle between nuclei in interspecies heterokaryons is
shown in Figs. 3B–3D. The mutant ICP27 polypeptides
fall into three categories with respect to their shuttling
abilities. First, the n504R-encoded protein is as capable
as the WT polypeptide of shuttling, with greater than 93%
of interspecies heterokaryons showing strong staining of
mouse nuclei (Table 2). An example of an interspecies
heterokaryon which shows shuttling of the n504R
polypeptide is shown in Figs. 3J–3L. Second, the
polypeptides encoded by the d1-2, M11, and M16 mu-
tants all show modest deficiencies in shuttling. Although
FIG. 3. Nuclear trafficking of mutant ICP27 polypeptides. Vero cells were infected with either WT or mutant HSV-1 using the cycloheximide release
protocol described in the text and fused to uninfected 3T6 cells. (A–D) WT-infected cells; (E–H) M15-infected cells; (I–L) n504R-infected cells. The
photomicrographs show either cells 30 min prior to fusion (A, E, and I) or single fields of cells after fusion (B–D, F–H, and J–L). Cells were stained
with anti-ICP27 monoclonal antibody H1119 (A, E, I and D, H, L) or Hoechst stain (C, G, and K). B, F, and J show phase-contrast images. The arrows
indicate 3T6 mouse nuclei within interspecies heterokarons. ICP27 staining in the nuclei indicated in D and L was scored as ‘‘strong,’’ while ICP27
staining in the nuclei indicated in H was negative. Bar, 20 mm.
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these proteins were present in .80% of mouse nuclei
within positive interspecies heterokaryons, the intensity
of ICP27 staining was significantly less than that for the
WT protein, with the majority of interspecies heterokary-
ons displaying weak staining (Table 2). Third, the mutant
protein encoded by M15 appears to be completely un-
able to shuttle. In two experiments, ;99 and ;89% of
mouse nuclei in interspecies heterokaryons were nega-
tive for M15 ICP27 staining. Moreover, those few mouse
nuclei which were positive stained only weakly. A repre-
sentative interspecies heterokaryon, exhibiting no de-
tectable shuttling of the M15 polypeptide, is shown in
Figs. 3F–3H. The results of this analysis show that some
lethal mutations in the ICP27 polypeptide can either
partially (d1-2, M11, and M16) or completely (M15) com-
promise its ability to shuttle between the nucleus and
cytoplasm.
In the experiment shown in Fig. 3, very little if any
ICP27 was seen in the infected monkey cytoplasm prior
to the fusion step, for either the WT or mutant proteins
(Figs. 3A, 3E, and 3I). However, after cell fusion, both the
WT- and the n504R-encoded proteins efficiently localized
to mouse nuclei. This clearly indicates that the bulk of
the protein imported into mouse nuclei must have origi-
nated from the infected monkey nuclei, rather than from
the cytoplasm, demonstrating bona fide shuttling. As
mentioned earlier, in some experiments, significant cy-
toplasmic staining was seen for WT ICP27 and some
mutant ICP27 molecules, but not for ICP4 and ICP8. It is
not known why the degree of ICP27 cytoplasmic staining
should vary depending on the experimental conditions,
nor why ICP27 should show more cytoplasmic localiza-
tion than ICP4 or ICP8. It is possible that these obser-
vations are related to the fact that ICP27 is a nuclear
shuttling protein.
Nuclear shuttling of ICP27 in the absence of viral
infection
To determine if viral infection or other viral proteins are
required for ICP27’s shuttling, we examined the ability of
ICP27 to shuttle when expressed by transient expression
in uninfected cells. Vero cells were transfected with
pC27, a plasmid which contains the ICP27 open reading
frame under the control of a human cytomegalovirus-
derived promoter. Transfected Vero cells were fused to
3T6 mouse cells in the presence of cycloheximide, and
the location of ICP27 was assessed in numerous inter-
species heterokaryons which exhibited ICP27 within
their Vero nuclei. ICP27 was found to be present within
the mouse nuclei of the great majority of these hetero-
karyons. A representative interspecies heterokaryon is
shown in Fig. 4. We conclude that the ability of ICP27 to
shuttle between nucleus and cytoplasm does not de-
pend on viral infection or the expression of other HSV-1
factors. Rather, nuclear shuttling appears to be an inher-
ent property of the ICP27 polypeptide.
DISCUSSION
Recently, it has become appreciated that some nu-
clear proteins are not confined to the nucleus once they
are transported there. Rather, these proteins continu-
ously shuttle between the nuclear and the cytoplasmic
compartments. Such nuclear shuttling proteins include
some of the heterogenous nuclear RNP (hnRNP) proteins
(Pin˜ol-Roma and Dreyfuss, 1992; Flach et al., 1994), sev-
eral nucleolar proteins (Borer et al., 1989; Meier and
Blobel, 1992), the human immundeficiency virus type 1
(HIV-1) Rev protein (Meyer and Malim, 1994; Kalland et
al., 1994), U1 small nuclear RNP-specific protein U1A
(Kambach and Mattaj, 1992), steroid hormone receptors
(Giuochon-Mantel et al., 1991), heat shock-related pro-
teins (Mandell and Feldherr, 1990), and the protein ki-
nase A inhibitor peptide (PKI) (Fantozzi et al., 1994).
Although the physiological significance of nuclear shut-
tling is not known in all cases, some shuttling proteins
which bind RNA appear to have roles in mRNA export.
Thus, the shuttling protein hnRNP A1 is associated with
RNA polymerase II-derived transcripts in both the nu-
cleus and cytoplasm and may directly mediate the nu-
cleocytoplasmic transport of these molecules (Pin˜ol-
Roma and Dreyfuss, 1992). HIV-1 Rev is involved in the
nuclear export of viral intron-containing mRNAs, medi-
ated via binding of Rev to the Rev-response element
within these mRNAs (Cullen, 1994; Fischer et al., 1994).
HSV-1 ICP27, an essential regulatory factor, has re-
cently been shown to possess RNA-binding activity
TABLE 2
Trafficking of Mutant ICP27 Molecules
within Interspecies Heterokaryons
Virus
No. of
heterokaryons
examined
ICP27 staining within mouse
nuclei of interspecies
heterokaryons (%)
Positive
Negative11a 1b
Expt. 1
WT 220 85.0 8.6 6.4
M15 254 0.4 0.8 98.8
d1-2 231 19.6 60.9 19.6
Expt. 2
WT 254 83.5 14.6 1.9
n504R 247 93.5 5.3 1.2
M11 281 33.1 58.7 8.2
M15 287 0 11.5 88.5
M16 249 32.1 62.7 5.2
a (11) Strong ICP27 staining within 3T6 nuclei (visually comparable
in intensity to that observed in Vero nuclei of same heterokaryon).
b (1) Weak ICP27 staining within 3T6 nuclei (visually less than half
the staining intensity observed in Vero nuclei of same heterokaryon).
133NUCLEAR SHUTTLING OF HSV ICP27
(Brown et al., 1995; Ingram et al., 1996; Mears and Rice,
1996). In addition, it is known to have a number of
posttranscriptional effects on viral and cellular gene ex-
pression, including alterations to the nucleocytoplasmic
transport of viral mRNAs (Phelan et al., 1996). Given the
similarities between ICP27 and some of the known nu-
clear shuttling proteins, we asked in this work whether
ICP27 shuttles between the nucleus and cytoplasm. The
results of our experiments demonstrate that ICP27 is a
very active shuttling protein, as it can efficiently traffic
between nuclei in interspecies heterokaryons. Further-
more, ICP27 can shuttle even when transiently ex-
pressed in uninfected cells, indicating that its shuttling
does not require viral infection or any other viral compo-
nents.
Our finding that low levels of ICP4 and ICP8 are im-
ported into mouse nuclei in some interspecies hetero-
karyons raises the possibility that HSV-1 nuclear pro-
teins ICP4 and ICP8 also are shuttling proteins, albeit
weak ones. However, an alternate and more trivial inter-
pretation of the data is that there is a low level of ICP8
and ICP4 in the cytoplasm of infected monkey cells prior
to heterokaryon formation and that this cytoplasmic pro-
tein is imported into mouse nuclei after cell fusion, re-
sulting in some weakly positive nuclei. At present, we
cannot distinguish between these two possibilities.
The capacity of a nuclear protein to shuttle demon-
strates that its nuclear import is counterbalanced to
some extent by its nuclear export. Although much has
been elucidated with respect to nuclear protein import,
the process of nuclear protein export is less well under-
stood (for recent reviews, see Go¨rlich and Mattaj, 1996;
Moore, 1996; Nigg, 1997). Two pathways for nuclear
protein export have been proposed (Michael et al., 1995).
First, it has been suggested that nuclear export can be a
passive process which occurs for nuclear proteins which
do not have a means of nuclear retention (Laskey and
Dingwall, 1993; Schmidt-Zachmann et al., 1993). Other
nuclear proteins possess specific nuclear export se-
quences (NESs) which mediate their active export, pre-
sumably via interactions with cellular transport machin-
ery. Such sequences have been identified in Rev (Fischer
et al., 1995; Wen et al., 1995; Meyer et al., 1996), PKI (Wen
et al., 1995), hnRNP A1 (Michael et al., 1995), RANBP1
(Richards et al., 1996), and HTLV-1 Rex (Kim et al., 1996;
Palmieri and Malim, 1996). The Rev, Rex, RANBP1, and
PKI NESs consist of short leucine-rich segments,
whereas the hnRNP A1 NES, termed M9, is a 38-residue
sequence which contains no leucine residues and is
glycine-rich. In general, NES-containing proteins exhibit
rapid nuclear shuttling (within 1 h), whereas the shuttling
of proteins lacking NESs is a slower process.
Although we have previously characterized ICP27’s
nuclear localization signals (Mears et al., 1995), the sig-
nals and mechanisms involved in ICP27’s nuclear export
are unknown. ICP27 exhibits rapid shuttling, in that a
substantial fraction of ICP27 can traffic between nuclei in
the 1-h time frame of the interspecies heterokaryon as-
say. Based on this, we speculate that ICP27’s nuclear
export is mediated by an NES. ICP27 does not contain
any sequence which is obviously related to the M9 NES,
but it does possess several short sequences which bear
some resemblance to leucine-rich NESs. It is also pos-
sible that ICP27 does not possess an NES that directly
interacts with the cellular export machinery, but rather
shuttles because it associates with a protein or macro-
molecular complex which does possess such a signal.
FIG. 4. Shuttling of ICP27 in transfected cells. Vero cells were
transiently transfected with a plasmid expressing ICP27, and the trans-
fected cells were subjected to the interspecies heterokaryon assay as
described in the text. A field of cells containing a representative
interspecies heterokaryon is shown. (A) Phase-contrast image; (B)
Hoechst staining; (C) ICP27 staining using monoclonal antibody H1119.
Arrow indicates 3T6 nucleus in heterokaryon. Bar, 20 mm.
134 MEARS AND RICE
Given ICP27’s ability to bind to RNA, it is interesting to
speculate that ICP27 might bind to pre-mRNA in the
nucleus and be transported to the cytoplasm in direct
association with these molecules.
Our analysis of mutant ICP27 polypeptides provides
information about the determinants in ICP27 which affect
its nuclear export. We find that the ICP27 molecules
encoded by d1-2, M11, and M16 are significantly reduced
in their shuttling ability. It is interesting that the d1-2
mutation results in the deletion of residues 12–63, dis-
rupting a potential leucine-rich NES near the N-terminus
of ICP27 (residues 7–20: MLIDLGLDLSDSDL). The most
deleterious mutation, however, is the C-terminal muta-
tion M15, which completely abrogates shuttling. The M15
mutation alters residues 465 and 466 from PG to LE and
is in a region of the protein which is very closely con-
served among herpesviral ICP27 homologues (Brown et
al., 1995). It is possible that the M15 mutation disrupts a
critical NES or affects ICP27’s ability to interact with an
NES-containing protein or complex. It is perhaps note-
worthy that there is a NES-resembling leucine-rich re-
gion very near to the M15 alterations (residues 469–476:
MAGLIEIL). Another possibility is that the M15 mutation
decreases ICP27’s nuclear export indirectly by increas-
ing its nuclear retention, perhaps by trapping ICP27 in a
nonproductive interaction in the nucleus. A precedent for
this notion comes from studies of the hnRNP C proteins,
which possess nuclear retention signals that can over-
ride the effects of NESs (Nakielny and Dreyfuss, 1996).
While this paper was being revised, a study by Soli-
man et al. was published which independently con-
cluded that ICP27 can shuttle between the nucleus and
cytoplasm of HSV-1-infected cells (Soliman et al., 1997).
These investigators demonstrated that ICP27 accumu-
lates in the cytoplasm when cells are treated with acti-
nomycin D. This effect is characteristic of several shut-
tling proteins and appears to reflect a linkage between
their nuclear import and ongoing RNA polymerase II
transcription (Pin˜ol-Roma and Dreyfuss, 1991, 1992). In
contrast to our findings, however, Soliman et al. reported
that ICP27 was unable to shuttle when expressed alone
in transfected cells, but could be activated to shuttle by
the coexpression of an HSV-1 L gene transcript. The
reason for this apparent discrepancy is unknown, but
may reflect the two different methods used to assay
shuttling.
The key question raised by the discovery of ICP27’s
shuttling activity concerns its biological function. The
finding that the lethal M15 mutation inactivates ICP27’s
shuttling argues that this activity is essential. The M15
virus is WT for viral DNA replication, but is unable to
induce certain L gene mRNAs (Rice and Lam, 1994). This
suggests that ICP27’s shuttling plays an important role in
the activation of HSV-1 L genes. It is interesting that the
n504R mutation also destroys ICP27’s ability to stimulate
L genes (Rice and Knipe, 1990) but does not affect its
shuttling. These results suggest that the C-terminal por-
tion of ICP27 is involved in both the shuttling activity and
an additional function required for late gene expression.
How might the shuttling of ICP27 aid in the transactiva-
tion of viral L genes? One attractive idea is that ICP27
stimulates the nuclear export of L gene transcripts by
binding to them in the nucleus and escorting them to the
cytoplasm. Experiments are currently in progress in our
laboratory to test this model.
MATERIALS AND METHODS
Cells, viruses, and infections
Vero (African green monkey kidney) cells and 3T6
(mouse fibroblast) cells were obtained from the Ameri-
can Type Culture Collection (Rockville, MD) and were
propagated in Dulbecco’s modified Eagle’s medium con-
taining 5% heat-inactivated fetal bovine serum (GIBCO).
HSV-1 infections were carried out at a m.o.i. of 10 PFU
per cell, and infected cells were maintained in 199V
media [199 media (GIBCO), 2% heat-inactivated newborn
calf serum (GIBCO)]. The HSV-1 strain KOS1.1 (Hughes
and Munyon, 1975) was the WT strain used in these
experiments. The HSV-1 ICP27 mutants d1-2, M11, M15,
M16, and n504R have been described previously (Rice
and Knipe, 1990; Rice et al., 1993; Rice and Lam, 1994).
Plasmid construction
To examine the ability of ICP27 to shuttle in the ab-
sence of other viral proteins, ICP27 was expressed in
Vero cells by transient transfection. The plasmid used for
transfection was pC27, which contains the open reading
frame of the ICP27 gene under the control of a minimal
CMV promoter. To construct pC27, the plasmid pBS27
(Rice and Lam, 1994) was linearized by cleavage with
DrdI, which cuts just upstream of ICP27’s initiation
codon. The DNA ends were made blunt by treatment with
with T4 DNA polymerase, and EcoRI linkers were ligated
on. After treatment with EcoRI, the 2.0-kb ICP27 gene-
containing fragment was cloned into the vector
pUHD10-3 (Gossen and Bujard, 1992), previously linear-
ized with EcoRI and treated with calf alkaline phos-
phatase. After cloning in Escherichia coli, the orientation
of the ICP27 gene insert in pC27 was verified by restric-
tion enzyme digestion.
Interspecies heterokaryon assay for nuclear shuttling
To study the ability of HSV-1 nuclear proteins to shuttle
between nucleus and cytoplasm, a modified version of
an interspecies heterokaryon assay (Borer et al., 1989;
Pin˜ol-Roma and Dreyfuss, 1992) was used. Vero cells
grown on circular coverslips in 12-well trays (1.5 3 105
cells/well) were infected with HSV-1. Four hours postin-
fection (p.i.), 3T6 cells were plated (3.5 3 105 cells/well)
onto the infected Vero cells in 199V medium containing
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50 mg/ml cycloheximide and 0.15% human immune glob-
ulin (Armour Pharmaceutical Company, Kankakee, IL).
Four hours later, the cycloheximide concentration was
increased to 100 mg/ml. After 30 min, the cells were
washed in phosphate-buffered saline (PBS). Cell fusion
was performed by the addition of 50% polyethylene gly-
col (w/w) in Hanks’ balanced media (GIBCO) to each
coverslip for 2 min. After fusion, the coverslips were
washed in PBS four times. All reagents and solutions
involved in the fusion process were prewarmed to 37°C.
After washing, the coverslips were returned to medium
containing 100 mg/ml cycloheximide for 60 min, after
which time the cells were fixed for immunofluorescence.
In some experiments, the level of ICP27 in infected
cells was increased by using a ‘‘cycloheximide release’’
protocol (Honess and Roizman, 1974). This was done by
infecting Vero cells in the presence of 50 mg/ml cyclo-
heximide to allow for the enhanced accumulation of IE
mRNAs. Four hours p.i., the cycloheximide-containing
medium was removed, the cells were washed, and new
media without cycloheximide were added. This allowed
the accumulated IE mRNAs to be translated. After 2 h,
3T6 cells were added in medium containing cyclohexi-
mide, and the interspecies heterokaryon assay was car-
ried out as described above.
To examine the potential of transiently expressed
ICP27 to shuttle, the interspecies heterokaryon assay
was applied to transfected cells using a protocol similar
to that of Michael et al. (1995). Vero cells grown in 25-cm2
flasks were transfected with 8 mg of pC27 using the
calcium phosphate precipitation procedure as described
previously (Rice and Knipe, 1990). Twenty-four hours
later, the transfected Vero cells were transfered to cov-
erslips in 12-well trays (2 3 105 cells/well). After approx-
imately 12 h, 3T6 mouse cells were plated (3 3 105/well)
in the presence of 50 mg/ml cycloheximide onto the
transfected Vero cells. After 4 h, the cycloheximide con-
centration in the media was increased to 100 mg/ml, and
the interspecies heterokaryon assay was performed as
described above.
Immunofluorescence
Cells were fixed with 3.7% formaldehyde, permeabil-
ized with acetone, and processed for immunofluores-
cence as described by Quinlan et al. (1984). The primary
antibodies used were the mouse monoclonals H1119,
H1115, and H1114, which are specific for ICP27, ICP8,
and ICP4, respectively. All three were obtained from the
Goodwin Institute for Cancer Research (Plantation, FL).
The antibodies were diluted 1:600, 1:1000, and 1:800,
respectively, in PBS. The secondary antibody used for
indirect immunofluorescence was tetramethylrhodamine
isothiocyanate-conjugated anti-mouse immunoglobulin
G (IgG) (Jackson ImmunoResearch Laboratories Inc.,
Mississauga, Ontario), diluted 1:200 in PBS. Cells were
costained with 0.5 mg/ml Hoechst dye No. 33258 (Sigma)
diluted in PBS and a 1:100 dilution in PBS of Bodipy-FL
phallocidin (Molecular Probes Inc., Eugene, OR). The
cells were visualized with a Zeiss Axioskop 20 fluores-
cence microscope equipped with a PlanNeofluar 633
objective lens. Photographic negatives were converted
to electronic files using an ArcusII desktop scanner
(AGFA) and a Power Macintosh 8500/150 computer, and
composite figures were made using the Photoshop pro-
gram (version 3.0, Adobe).
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